In a May 8 article published by Law360, intellectual property litigation partner Peter Brody (Washington, D.C.) discusses how the U.S. Supreme Court will address the intersection of the Lanham Act and the Federal Food, Drug and Cosmetic Act in the POM Wonderful LLC v. Coca-Cola Co. case. In the article, titled “POM V. Coke May Impact Many FDA-Regulated Products,” he provides background on the false advertising case and discuss how the decision may provide needed clarity but is unlikely to address the full range of advertising claims that may be challenged for every category of FDA-regulated product.
Click here to view the article.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.